NCT06891833 2025-10-02A Study of BL-M07D1 With or Without Pertuzumab Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast CancerSichuan Baili Pharmaceutical Co., Ltd.Phase 2/3 Recruiting120 enrolled